(Q43586003)

24 November 2017

title

Smaller LDL particle size in women with polycystic ovary syndrome compared to controls (English)

1 reference

polycystic ovary syndrome

24 November 2017

main subject

1 reference

1 reference

Dejager S

1

1 reference

24 November 2017

Pichard C

2

1 reference

24 November 2017

Giral P

3

1 reference

24 November 2017

Bruckert E

4

1 reference

24 November 2017

Federspield MC

5

1 reference

24 November 2017

Beucler I

6

1 reference

24 November 2017

Turpin G

7

1 reference

24 November 2017

publication date

1 April 2001

1 reference

24 November 2017

published in

Clinical Endocrinology

1 reference

24 November 2017

volume

54

1 reference

24 November 2017

issue

4

1 reference

24 November 2017

page(s)

455-462

1 reference

LDL particle size distribution. Results from the Framingham Offspring Study

24 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01245.X

A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01245.X

Low density lipoprotein particle size and risk factors of insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01245.X

Influences of weight, body fat patterning and nutrition on the management of PCOS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01245.X

Alterations in low-density lipoprotein and high-density lipoprotein subclasses among Hispanic women with polycystic ovary syndrome: influence of insulin and genetic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01245.X

A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01245.X

Subjects with polycystic ovaries without hyperandrogenaemia exhibit similar disturbances in insulin and lipid profiles as those with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01245.X

Body fat distribution has weight-independent effects on clinical, hormonal, and metabolic features of women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01245.X

Mortality of women with polycystic ovary syndrome at long-term follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01245.X

Interrelations between sex hormone-binding globulin (SHBG), plasma lipoproteins and cardiovascular risk.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01245.X

Lipoprotein correlates of LDL particle size

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01245.X

Ambulatory blood pressure profiles and plasminogen activator inhibitor (PAI-1) activity in lean women with and without the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01245.X

LDL subclass phenotypes and the insulin resistance syndrome in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01245.X

Coronary Heart Disease Risk Factors in Women With Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2001.01245.X

10.1046/J.1365-2265.2001.01245.X

21 January 2018

Identifiers

DOI

1 reference

24 November 2017

1 reference